Published on 16 Dec 2021 on Zacks via Yahoo Finance
Cyclerion Therapeutics, Inc. (CYCN) has been on a downward spiral lately with significant selling pressure. After declining 38.9% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.
How to Determine if a Stock is Oversold
We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.